CGS-authored

Politics has long reined in stem cell research, but Tuesday's election may have put the spurs to it, industry insiders say.

Stem cell research was a hot topic in the Nov. 7 races. Support for it may have been a selling point for a number of successful candidates. In Missouri, for example, Democratic challenger Claire McCaskill defeated incumbent Sen. Jim Talent, while state voters passed a state constitutional amendment establishing the right to do stem cell research.

Rep. Nancy Pelosi, D-San Francisco, in line to be speaker of the House, said she will make one of her top priorities in the first 100 hours of the new Congress to overturn limits on government stem cell funding.

That signals a shift from the conservative political climate in which the Bush administration restricted federal funding on stem cells derived from human embryos for more than five years.

Companies like Advanced Cell Technology, an Alameda stem cell company, see a possibility that Congress will overturn Bush's limits.

Such a shift would primarily benefit academic laboratories, though companies in the field might gain grant...